{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:47:04Z","timestamp":1790182024274,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.lpm.2007.01.029","type":"journal-article","created":{"date-parts":[[2008,1,26]],"date-time":"2008-01-26T05:23:55Z","timestamp":1201325035000},"page":"922-927","source":"Crossref","is-referenced-by-count":13,"special_numbering":"P2","title":["Traitement des\u00a0vascularites syst\u00e9miques associ\u00e9es aux\u00a0ANCA"],"prefix":"10.1016","volume":"36","author":[{"given":"Lo\u00efc","family":"Guillevin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pagnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2007.01.029_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitisassociated with antineutrophil cytoplasmic antibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.01.029_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2007.01.029_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.01.029_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","article-title":"Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients","volume":"78","author":"Guillevin","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2007.01.029_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2007.01.029_bib6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0755-4982(05)84104-1","article-title":"Pathog\u00e9nie des vascularites syst\u00e9miques primitives (I): Les vascularites ANCA positives","volume":"34","author":"Guilpain","year":"2005","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2007.01.029_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2169\/internalmedicine.42.313","article-title":"When should immunosuppressants be prescribed to treat systemic vasculitides?","volume":"42","author":"Guillevin","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.lpm.2007.01.029_bib8","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","article-title":"A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener\u2019s granulomatosis","volume":"40","author":"Guillevin","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.01.029_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1681\/ASN.V7133","article-title":"Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis","volume":"7","author":"Nachman","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.01.029_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/90.6.401","article-title":"Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis","volume":"90","author":"Adu","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.lpm.2007.01.029_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gammaglobulins","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.01.029_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","article-title":"Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity","volume":"93","author":"Jayne","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.lpm.2007.01.029_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/jaut.1993.1018","article-title":"ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin","volume":"6","author":"Jayne","year":"1993","journal-title":"J Autoimmun"},{"key":"10.1016\/j.lpm.2007.01.029_bib14","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/rheumatology\/35.11.1150","article-title":"Intravenous immunoglobulins as sole therapy for systemic vasculitis","volume":"35","author":"Jayne","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.lpm.2007.01.029_bib15","series-title":"Vascularites. elGFdEd, Intravenous immunoglobulins for relapses of ANCA-associated systemic vasculitides: final analysis of a prospective, open and multicenter trial","author":"Martinez","year":"2005"},{"key":"10.1016\/j.lpm.2007.01.029_bib16","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.01.029_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis","volume":"352","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.01.029_bib18","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-\u03b1 antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2007.01.029_bib19","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W","article-title":"Response of Wegener\u2019s granulomatosis to anti-CD20 chimeric monoclonal antibody therapy","volume":"44","author":"Specks","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.01.029_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2007.01.029_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","article-title":"Rituximab for refractory Wegener\u2019s granulomatosis: report of a prospective, open-label pilot trial","volume":"173","author":"Keogh","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2007.01.029_bib22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.2005.044420","article-title":"Lack of efficacy of Rituximab in Wegener\u2019s Granulomatosis with refractory granulomatous manifestations","volume":"65","author":"Aries","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2007.01.029_bib23","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/bjo.2005.075689","article-title":"Successful treatment of Wegener's granulomatosis associated scleritis with rituximab","volume":"89","author":"Cheung","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.lpm.2007.01.029_bib24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/ndt\/gfh599","article-title":"Effective therapeutic use of rituximab in refractory Wegener\u2019s granulomatosis","volume":"20","author":"Ferraro","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2007.01.029_bib25","series-title":"Randomised trial of plasma exchange versus methyl prednisolone for severe renal vasculitis. submitted","author":"Jayne","year":"2005"},{"key":"10.1016\/j.lpm.2007.01.029_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.lpm.2007.01.029_bib27","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2007.01.029_bib28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-129-5-199809010-00004","article-title":"Interferon-\u03b1 treatment of four patients with the Churg-Strauss syndrome","volume":"129","author":"Tatsis","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2007.01.029_bib29","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJMc061914","article-title":"Omalizumab for asthma","volume":"355","author":"Winchester","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.01.029_bib30","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1136\/ard.2004.032664","article-title":"Leucoencephalopathy after treatment of Churg-Strauss syndrome with interferon-\u03b1","volume":"64","author":"Metzler","year":"2005","journal-title":"Ann Rheum Dis"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498207001765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498207001765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:52:02Z","timestamp":1630608722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498207001765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0755498207001765"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2007.01.029","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}